## Abstract ## Objective To determine whether eyedrop administration of an anti‐CD4 monoclonal antibody (mAb) is effective in the treatment of Sjögren's syndrome (SS) using a mouse model of the disease. ## Methods The anti‐CD4 mAb was administered daily into the eyes of mice with SS from ages 4
Effective treatment with oral administration of rebamipide in a mouse model of Sjögren's syndrome
✍ Scribed by Masayuki Kohashi; Naozumi Ishimaru; Rieko Arakaki; Yoshio Hayashi
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 904 KB
- Volume
- 58
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objective A wide spectrum of extraglandular manifestations may occur in patients with Sjögren's syndrome (SS), but the mechanisms responsible for in vivo progression are still obscure. We undertook this study to evaluate the age‐related changes during the development of extraglandul
Our recent study suggested that the 120-kDa § -fodrin molecule may be an important autoantigen in the pathogenesis of Sjögren's syndrome, and anti-120-kDa § -fodrin antibodies have been detected in patients with Sjögren's syndrome. Here we have analyzed anti-120-kDa § -fodrin immune responses during